CD4 and acute respiratory distress syndrome: Stimulation of PBMC with MP_S and MP_CD4_R led to consistent activation of SARS-CoV-2-specific CD4+ T cells (Fig. 2) in PBMC obtained from COVID-19 ARDS patients.